Institutional Ownership
Crinetics Pharmaceuticals In
CUSIP 22663K107COMCRNXQ1 2026
13D / 13G Filings
65
Schedule 13D/13G on record
Beneficial Filers
22
Distinct reporting persons
Largest Stake
15.0%
Max % of class reported
Institutional Holders
234
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
65 filings · latest Feb 5, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 5, 2026 | Farallon Capital Partners, L.P. | 13G/A | 8.5% | 8.02M | SEC |
| 2 | Nov 12, 2025 | Wellington Management Group LLP | 13G/A | 8.9% | 8.38M | SEC |
| 3 | Sep 8, 2025 | Farallon Capital Partners, L.P. | 13G | 6.0% | 5.63M | SEC |
| 4 | Aug 12, 2025 | Wellington Management Group LLP | 13G/A | 6.2% | 5.81M | SEC |
| 5 | May 12, 2025 | Fmr LLC | 13G/A | 15.0% | 13.96M | SEC |
| 6 | Apr 7, 2025 | The Vanguard Group | 13G/A | 10.0% | 9.31M | SEC |
| 7 | Feb 10, 2025 | Wellington Management Group LLP | 13G/A | 7.5% | 6.95M | SEC |
| 8 | Feb 7, 2025 | Fmr LLC | 13G/A | 10.4% | 9.63M | SEC |
| 9 | Feb 7, 2025 | Fmr LLC | 13G/A | 9.6% | 8.90M | SEC |
| 10 | Jan 30, 2025 | The Vanguard Group | 13G/A | 9.8% | 9.09M | SEC |
55 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Crinetics Pharmaceuticals In.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 15.76M | $572.40M |
| 2 | Blackrock, Inc. | 8.48M | $307.95M |
| 3 | Farallon Capital Management LLC | 8.34M | $302.84M |
| 4 | Wellington Management Group LLP | 8.16M | $296.27M |
| 5 | Driehaus Capital Management LLC | 6.40M | $232.30M |
| 6 | Janus Henderson Group PLC | 4.52M | $164.23M |
| 7 | Ecor1 Capital, LLC | 4.29M | $155.74M |
| 8 | Bellevue Group AG | 3.28M | $119.13M |
| 9 | Geode Capital Management, LLC | 2.48M | $90.12M |
| 10 | State Street Corp | 2.40M | $87.28M |